350 related articles for article (PubMed ID: 19151727)
61. Highly variable penetrance in subjects affected with cavernous cerebral angiomas (CCM) carrying novel CCM1 and CCM2 mutations.
Gianfrancesco F; Cannella M; Martino T; Maglione V; Esposito T; Innocenzi G; Vitale E; Liquori CL; Marchuk DA; Squitieri F
Am J Med Genet B Neuropsychiatr Genet; 2007 Jul; 144B(5):691-5. PubMed ID: 17440989
[TBL] [Abstract][Full Text] [Related]
62. Genetic Screening of Pediatric Cavernous Malformations.
Merello E; Pavanello M; Consales A; Mascelli S; Raso A; Accogli A; Cama A; Valeria C; De Marco P
J Mol Neurosci; 2016 Oct; 60(2):232-8. PubMed ID: 27561926
[TBL] [Abstract][Full Text] [Related]
63. Conditional deletion of Ccm2 causes hemorrhage in the adult brain: a mouse model of human cerebral cavernous malformations.
Cunningham K; Uchida Y; O'Donnell E; Claudio E; Li W; Soneji K; Wang H; Mukouyama YS; Siebenlist U
Hum Mol Genet; 2011 Aug; 20(16):3198-206. PubMed ID: 21596842
[TBL] [Abstract][Full Text] [Related]
64. [Cerebral cavernous malformation--its genetic and biological background].
Fujimura M; Tominaga T
Brain Nerve; 2008 Nov; 60(11):1271-4. PubMed ID: 19069160
[TBL] [Abstract][Full Text] [Related]
65. From Genes and Mechanisms to Molecular-Targeted Therapies: The Long Climb to the Cure of Cerebral Cavernous Malformation (CCM) Disease.
Retta SF; Perrelli A; Trabalzini L; Finetti F
Methods Mol Biol; 2020; 2152():3-25. PubMed ID: 32524540
[TBL] [Abstract][Full Text] [Related]
66. CCM2 expression parallels that of CCM1.
Seker A; Pricola KL; Guclu B; Ozturk AK; Louvi A; Gunel M
Stroke; 2006 Feb; 37(2):518-23. PubMed ID: 16373645
[TBL] [Abstract][Full Text] [Related]
67. Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation.
Zhang J; Clatterbuck RE; Rigamonti D; Chang DD; Dietz HC
Hum Mol Genet; 2001 Dec; 10(25):2953-60. PubMed ID: 11741838
[TBL] [Abstract][Full Text] [Related]
68. Update on Novel CCM Gene Mutations in Patients with Cerebral Cavernous Malformations.
Scimone C; Bramanti P; Alafaci C; Granata F; Piva F; Rinaldi C; Donato L; Greco F; Sidoti A; D'Angelo R
J Mol Neurosci; 2017 Feb; 61(2):189-198. PubMed ID: 28000143
[TBL] [Abstract][Full Text] [Related]
69. [Gene mutations in patients with hereditary cavernous malformations].
Belousova OB; Bulygina ES; Okishev DN; Prohorchuk EB; Tsygankova SV; Pronin IN; Shishkina LV; Ryzhova MV; Skryabin KG; Konovalov AN
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):66-72. PubMed ID: 28745674
[TBL] [Abstract][Full Text] [Related]
70. Relevance of CCM gene polymorphisms for clinical management of sporadic cerebral cavernous malformations.
Rinaldi C; Bramanti P; Scimone C; Donato L; Alafaci C; D'Angelo R; Sidoti A
J Neurol Sci; 2017 Sep; 380():31-37. PubMed ID: 28870584
[TBL] [Abstract][Full Text] [Related]
71. Recent insights into cerebral cavernous malformations: animal models of CCM and the human phenotype.
Chan AC; Li DY; Berg MJ; Whitehead KJ
FEBS J; 2010 Mar; 277(5):1076-83. PubMed ID: 20096037
[TBL] [Abstract][Full Text] [Related]
72. Generation of Cerebral Cavernous Malformation in Neonatal Mouse Models Using Inducible Cre-LoxP Strategy.
Choi JP; Zheng X
Methods Mol Biol; 2020; 2152():253-258. PubMed ID: 32524557
[TBL] [Abstract][Full Text] [Related]
73. Blood Flow Suppresses Vascular Anomalies in a Zebrafish Model of Cerebral Cavernous Malformations.
Rödel CJ; Otten C; Donat S; Lourenço M; Fischer D; Kuropka B; Paolini A; Freund C; Abdelilah-Seyfried S
Circ Res; 2019 Oct; 125(10):e43-e54. PubMed ID: 31495257
[TBL] [Abstract][Full Text] [Related]
74. Two Novel CCM2 Heterozygous Mutations Associated with Cerebral Cavernous Malformation in a Chinese Family.
Du Q; Shi Z; Chen H; Zhang Y; Wang J; Zhou H
J Mol Neurosci; 2019 Mar; 67(3):467-471. PubMed ID: 30701383
[TBL] [Abstract][Full Text] [Related]
75. Proteomic identification of the cerebral cavernous malformation signaling complex.
Hilder TL; Malone MH; Bencharit S; Colicelli J; Haystead TA; Johnson GL; Wu CC
J Proteome Res; 2007 Nov; 6(11):4343-55. PubMed ID: 17900104
[TBL] [Abstract][Full Text] [Related]
76. Low fluid shear stress conditions contribute to activation of cerebral cavernous malformation signalling pathways.
Li J; Zhao Y; Coleman P; Chen J; Ting KK; Choi JP; Zheng X; Vadas MA; Gamble JR
Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165519. PubMed ID: 31369819
[TBL] [Abstract][Full Text] [Related]
77. A Novel
Han G; Ma L; Qiao H; Han L; Wu Q; Li Q
Front Neurosci; 2020; 14():604350. PubMed ID: 33469417
[TBL] [Abstract][Full Text] [Related]
78. Cerebral cavernous malformations as a disease of vascular permeability: from bench to bedside with caution.
Yadla S; Jabbour PM; Shenkar R; Shi C; Campbell PG; Awad IA
Neurosurg Focus; 2010 Sep; 29(3):E4. PubMed ID: 20809762
[TBL] [Abstract][Full Text] [Related]
79. Generation and Application of the Zebrafish
Lu S; Hu M; Wang Z; Liu H; Kou Y; Lyu Z; Tian J
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33198188
[TBL] [Abstract][Full Text] [Related]
80. KRIT1: A Traffic Warden at the Busy Crossroads Between Redox Signaling and the Pathogenesis of Cerebral Cavernous Malformation Disease.
Perrelli A; Ferraris C; Berni E; Glading AJ; Retta SF
Antioxid Redox Signal; 2023 Mar; 38(7-9):496-528. PubMed ID: 36047808
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
